A Wesley Chapel based business is expanding its product line and seeking additional funding to increase its sales force and market presence.
is a proprietary invisible bandage product that provides a natural, safe, effective way to heal topical wounds. The product uses a unique nanoparticle emulsion technology to mimic the skin’s natural healing properties.
CEO and Founder Kerriann Greenhalgh, PhD an organic chemist and University of South Florida
graduate, created the product after being personally affected by inadequate over the counter wound care. Her husband contracted a serious MRSA infection from a small cut on his hand and almost lost the use of his entire hand. Her chemistry background led her to create an innovative solution that is now available for public use.
The company launched in August 2012 and has products for both veterinary and human use available in retail stores such as Amazon, Vitamin Discount Centers, Publix and Earth Origins as well as online.
They recently launched a Series A Fundraise, seeking funding to grow their market presence and expand their product line, with particular focus on the healthcare space. FDA clearance is currently being sought for the advanced liquid bandage, which will be used by physicians to protect surgical incisions.
"We’re looking to capitalize on the success we had the first two years," says Greenhalgh.
They are also looking to add additives to the natural product line such as vitamin E and tea tree oil.
Kericure was a recent participant in the Greater Tampa Chamber of Commerce’s
Startup Scholars program, which is cited as a big contributor to success. As a result of that program, Greenhalgh helped start a local networking group called the Consumer Products Club, which supports local businesses with shared resources, services, opportunities and ideas for marketing and distribution channels.
"We’re all working together and seeing growth across the board for everybody,” says Greenhalgh. “Each person is bringing unique experiences and successes to the table."
Writer: Megan Hendricks
Source: Kerriann Greenhalgh, KeriCure